Denmark to reconsider exclusion of Janssen and AstraZeneca vaccines

Denmark To Reconsider Exclusion Of Janssen And Astrazeneca Vaccines
The move was prompted by a two-week delay in the Danish vaccination programme. Photo: Getty Images.
Share this article

Thomson Reuters

Denmark's government on Monday asked the country's health authorities to reconsider a decision to exclude Johnson & Johnson's and AstraZeneca's Covid-19 shots from its vaccination programme.

The move was prompted by a two-week delay in the Danish vaccination programme to September due to delivery of fewer Moderna and CureVac vaccines than expected, Health Minister Magnus Heunicke said.

Denmark excluded the J&J and AstraZeneca vaccines over a potential link to a rare but serious form of blood clot.

"We are now further into the epidemic, and the vaccines from Johnson & Johnson and AstraZeneca have now been in use in Europe for some time," Mr Heunicke said.

"There is a larger database worldwide to assess the effect and side effects of the vaccines," he said.


The health authority found in early May that the benefits of using the Covid-19 vaccines did not outweigh the risk of causing the possible adverse effect in those who receive the vaccine.


Excluding the J&J vaccine, which accounts for around a third of Denmark's total contracted supplies of Covid-19 shots, delayed the country's vaccination calendar by up to four weeks, the health authority said.

Denmark had vaccinated 21 per cent of its population as of Monday.

Read More

Want us to email you top stories each lunch time?

Download our Apps
© 2021, developed by Square1 and powered by